Search alternatives:
marked decrease » marked increase (Expand Search)
marker decrease » larger decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
marked decrease » marked increase (Expand Search)
marker decrease » larger decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a marked » _ marked (Expand Search), a market (Expand Search), _ market (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
-
1
Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast.
Published 2025“…<p>Relationship between the Gender Representation Disparity Index (GRDI) and average explicit sex markers in film criticism, illustrating a decrease in markers as the GRDI moves toward a female-dominated cast.…”
-
2
-
3
-
4
-
5
-
6
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
7
A summary of the included study characteristics.
Published 2025“…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
8
-
9
-
10
-
11
-
12
Participants enrollment.
Published 2025“…There was a positive and good knowledge retention among caregivers of hypertensive patients after health education at the week six mark. …”
-
13
KAP assessment scores (n = 422).
Published 2025“…There was a positive and good knowledge retention among caregivers of hypertensive patients after health education at the week six mark. …”
-
14
-
15
-
16
-
17
-
18
-
19
-
20